Genmab — Maj 2021
-
God morgen.
-
Asien: Blandet udvikling med markante regionale
udsving.https://www.proinvestor.com/investornyt/674905/asien-blandet-udviling-med-markante-regionale-udsving -
Mandagens aviser med Topdanmark, Carlsberg og Novo Nordisk https://www.proinvestor.com/investornyt/674906/mandagens-aviser-med-topdanmark-carlsberg-og-novo-nordisk
-
Godmorgen. Forudsat at JvW og Stockbull stopper deres storudsalg af Genmab aktier, tror jeg vi har en skøn uge i sigte
-
Health Canada approves Darzalex + bortezomib + cyclophosphamide + dexamethasone to treat light chain amyloidosis https://medicalupdateonline.com/2021/05/health-canada-approves-darzalex-bortezomib-cyclophosphamide-dexamethasone-to-treat-light-chain-amyloidosis-janssen-biotech/
-
Aktier/åbning: Sur start på dagen med pres på Vestas og Ambu:
https://www.proinvestor.com/investornyt/674920/aktier-abning-sur-start-pa-dagen-med-pres-pa-vestas-og-ambu -
-
Researchers find CD38-targeting drugs may show promise against prostate cancer http://www.pharmatimes.com/news/researchers_find_cd38-targeting_drugs_may_show_promise_against_prostate_cancer_1369656
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind